Louvain-la-Neuve, Belgium, June 17, 2019, 17.35
Summary of the notification
IBA (Ion Beam Applications SA), the world’s leading provider of proton therapy solutions for the treatment of cancer, announces that it has to issue a transparency notification, in accordance with Article 14, al. 1 of the Transparency Law of May 2, 2007 on disclosure of major holdings, further to the notification received on June 14, 2019.
In its notification, la Société Fédérale de Participations et d’Investissement (including Belfius) has notified, that following an acquisition of IBA shares with voting rights, its total holding in IBA SA has crossed upwards the 3 % threshold on June 11, 2019.
In details, on June 11, 2019, la Société Fédérale de Participations et d’Investissement owned 961.954 IBA shares with voting rights, representing 3,19% of the total number of shares issued by IBA (30 122 528).
Content of the notification
- Reason for the notification: Acquisition or disposal of voting securities or voting rights
- Persons subject to the notification requirement: la Société Fédérale de Participations et d’Investissement
- Date on which the threshold is crossed: 11/06/2019
- Threshold crossed (in %): 3%
- Denominator: 30 122 528
- Notified details: (extract of the received notification form)
| A) Voting rights | Previous notification | After the transaction | ||||
| # of voting rights | # of voting rights | % of voting rights | ||||
| Holders of voting rights | Linked to securities | Not linked to the securities | Linked to securities | Not linked to the securities | ||
| L’Etat belge | 0 | 0 | 0 | 0,00% | 0,00% | |
| Société Fédérale de Participation et d’Investissement | 0 | 58.200 | 0 | 0,19% | 0,00% | |
| Belfius Banque SA | 0 | 0 | 0 | 0,00% | 0,00% | |
| Belfius Insurance SA | 0 | 903.754 | 0 | 3,00% | 0,00% | |
| TOTAL | 961.954 | 0 | 3,19% | 0,00% | ||
| B) Equivalent financial instruments | After the transaction | |||||
| Holder of equivalent financial instruments | Type of financial instrument | Expiration date | Exercise period or date | # of voting rights that may be acquired if the instrument is exercised | % of voting rights | Settlement |
| TOTAL | 0 | 0,00% | ||||
| TOTAL (A & B) | # of voting rights | %of voting rights | ||||
| 961.954 | 3,19% | |||||
- Full chain of controlled undertakings through which the holding is effectively held
La Sociéte Fédérale de Participations et d’Investissement S.A. is the parent company of Belfius Bank S.A (ex. Dexia Bank), which in its turn is the parent company of Belfius Insurance S.A. La Société Fédérale de Participations et d’Investissement S.A. acts in its own name and on behalf of the Belgian State. The Belgian State holds 100 % of La Société Fédérale de Participations et d’Investissement.
For further information, please contact:
IBA
Stephanie Bauwin
Legal Counsel
+32 10 203 924
legal@iba-group.com
About IBA
IBA (Ion Beam Applications S.A.) is a global medical technology company focused on bringing integrated and innovative solutions for the diagnosis and treatment of cancer. The company is the worldwide technology leader in the field of proton therapy, considered to be the most advanced form of radiation therapy available today. IBA’s proton therapy solutions are flexible and adaptable, allowing customers to choose from universal full-scale proton therapy centers as well as compact, single room solutions. In addition, IBA also has a radiation dosimetry business and develops particle accelerators for the medical world and industry. Headquartered in Belgium and employing about 1,500 people worldwide, IBA has installed systems across the world.
IBA is listed on the pan-European stock exchange NYSE EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at: www.iba-worldwide.com
Attachment
